Quantitative Proteomic profiling identifies protein correlates to EGFR kinase inhibition

Clinical oncology is hampered by a lack of tools to accurately assess a patient’s response to pathway-targeted therapies. Serum and tumor cell surface proteins whose abundance, or change in abundance in response to therapy, differentiates patients responding to a therapy from patients not-responding...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kani, Kian, Faca, Vitor M., Hughes, Lindsey D., Zhang, Wenxuan, Fang, Qiaojun, Shahbaba, Babak, Luethy, Roland, Erde, Jonathan, Schmidt, Joanna, Pitteri, Sharon J., Zhang, Qing, Katz, Jonathan E., Gross, Mitchell E., Plevritis, Sylvia K., McIntosh, Martin W., Jain, Anjali, Hanash, Sam, Agus, David B., Mallick, Parag
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3959865/
https://ncbi.nlm.nih.gov/pubmed/22411897
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-11-0852
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados